Literature DB >> 19020820

HIV-1 recombination: an experimental assay and a phylogenetic approach.

Michael D Moore1, Mario P S Chin, Wei-Shau Hu.   

Abstract

The generation of genetic diversity is a fundamental characteristic of HIV-1 replication, allowing the virus to successfully evade the immune response and antiviral therapies. Although mutations are the first step towards diversity, mixing of the mutations through the process of recombination increases the variation and allows for the faster establishment of advantageous strains within the viral population. Therefore, studying recombination of HIV-1 provides insights into not only the mechanisms of HIV-1 replication but also into the potential for spread of antiviral drug resistance mutations within and across viral subtypes. This chapter describes, in detail, a highly sensitive recombination assay designed to measure the frequency of recombination between two viruses. This assay allows us to investigate the requirements, mechanisms, and final products of recombination. Additionally, software-based phylogenetic tools are described in this chapter, which allow for the identification of specific recombination events within patient samples or viral progeny from the recombination assay.

Entities:  

Mesh:

Year:  2009        PMID: 19020820      PMCID: PMC6785042          DOI: 10.1007/978-1-59745-170-3_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Comparison of the genetic recombination rates of human immunodeficiency virus type 1 in macrophages and T cells.

Authors:  Jianbo Chen; Terence D Rhodes; Wei-Shau Hu
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events.

Authors:  Terence D Rhodes; Olga Nikolaitchik; Jianbo Chen; Douglas Powell; Wei-Shau Hu
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Identification of a major restriction in HIV-1 intersubtype recombination.

Authors:  Mario P S Chin; Terence D Rhodes; Jianbo Chen; William Fu; Wei-Shau Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-14       Impact factor: 11.205

4.  Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning.

Authors:  M O Salminen; J K Carr; D S Burke; F E McCutchan
Journal:  AIDS Res Hum Retroviruses       Date:  1995-11       Impact factor: 2.205

5.  A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences.

Authors:  A C Siepel; A L Halpern; C Macken; B T Korber
Journal:  AIDS Res Hum Retroviruses       Date:  1995-11       Impact factor: 2.205

Review 6.  Generation of high-titer pseudotyped retroviral vectors with very broad host range.

Authors:  J K Yee; T Friedmann; J C Burns
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

7.  Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.

Authors:  K S Lole; R C Bollinger; R S Paranjape; D Gadkari; S S Kulkarni; N G Novak; R Ingersoll; H W Sheppard; S C Ray
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways.

Authors:  Que Dang; Jianbo Chen; Derya Unutmaz; John M Coffin; Vinay K Pathak; Douglas Powell; Vineet N KewalRamani; Frank Maldarelli; Wei-Shau Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-05       Impact factor: 11.205

  8 in total
  2 in total

1.  Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.

Authors:  Ujjwal Rathore; Piyali Saha; Sannula Kesavardhana; Aditya Arun Kumar; Rohini Datta; Sivasankar Devanarayanan; Raksha Das; John R Mascola; Raghavan Varadarajan
Journal:  J Biol Chem       Date:  2017-04-26       Impact factor: 5.157

2.  Subtype-specific differences in the human immunodeficiency virus type 1 reverse transcriptase connection subdomain of CRF01_AE are associated with higher levels of resistance to 3'-azido-3'-deoxythymidine.

Authors:  Krista A Delviks-Frankenberry; Galina N Nikolenko; Frank Maldarelli; Saiki Hase; Yutaka Takebe; Vinay K Pathak
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.